Posts Tagged ‘Healthcare’
Azure Cell Therapies Secures Innosuisse Grant to Advance Parkinson Disease Treatment
Azure Cell Therapies, a University of Geneva spinoff at the forefront of regenerative medicine, has been awarded a CHF 650,000 grant from Innosuisse, Switzerland’s innovation agency, to advance its pioneering cell-replacement therapies for Parkinson’s disease. Rooted in over 20 years of research from the University of Geneva and backed by over CHF 8 million…
Read MoreOneDoc Merges With Medicosearch
OneDoc, the leading Swiss platform for booking online medical appointments, has acquired Medicosearch. This transaction is another important step in the development of the Geneva-based company, consolidating its position as the leading player in digital healthcare in Switzerland, with over 13,000 registered healthcare professionals and more than 350,000 consultations booked online each month. The new…
Read MoreCarewell Wins the 2025 PERL Trophy
The 23rd edition of the Prix Entreprendre Lausanne Région (PERL) took place on Wednesday 7 May, at Beaulieu-Lausanne, gathering around 300 leaders from politics, business, and academia. The prestigious Lausanne Région Trophy, worth CHF 50,000, was awarded to Carewell, a company based in Pully, for its innovative project at the intersection of technology and social…
Read MoreSwiss Medical Network joins the Mayo Clinic Care Network
Swiss Medical Network (Vaud – Switzerland) and Mayo Clinic are proud to announce that seven clinics and centres of Swiss Medical Network have joined the Mayo Clinic Care Network, becoming the first healthcare provider in Western Europe to enter the collaboration. The agreement includes Clinique de Genolier, Privatklinik Bethanien in Zurich, Clinica Sant’Anna in Lugano…
Read MoreBioscibex, Inkocell Therapeutics, and OrthoSens Supported By Venture Kick
Bioscibex, Inkocell Therapeutics, and OrthoSens were selected at Venture Kick’s second financial and entrepreneurial support stage and get each a CHF 40’000 support. These three Swiss Health Valley startups reshape biopharma, oncology, and orthopedic recovery. Bioscibex, Inkocell Therapeutics, and OrthoSens have progressed to the second stage of Venture Kick, securing support to drive their innovations…
Read MoreAerospec, Carewell, OptiZone and SaisiR Finalists of the PERL Prize
Four Swiss Health Valley start-ups selected from the 5 finalists in the 23rd Prix Entreprendre Lausanne Région (PERL): Aerospec, Carewell, OptiZone and SaisiR. Nearly 60 companies from the Lausanne region applied for the PERL 2025 awards. Only five have been selected for the Awards Ceremony, to be held on Wednesday 7 May, and only one…
Read MoreNagi Bioscience Partners With Rhino Bio Inc. To Expand In South Korea
Nagi Bioscience, a pioneering Swiss company specializing in cutting-edge laboratory technologies for alternative model organisms research, announced a strategic partnership with Rhino Bio Inc., a leading distributor for next–generation analytical systems in South Korea. The partnership accelerates Nagi Bioscience’s expansion into the South Korean market, driven by strong demand for its flagship product, SydLab™ One.…
Read MoreMoleSens Wins The EPFL Startup Champion Seed Night
On April 10th, 2025, the Startup Champions Seed Night once again confirmed its place as a cornerstone event in Western Switzerland’s innovation landscape. Co-organized by EPFL Alumni, the EPFL Vice Presidency for Innovation, and Venturelab, the 14th edition brought together nearly 500 attendees—both in person at the Rolex Forum and online—to celebrate the next generation…
Read More2024: A Year of Growth and Innovation at Biopôle
2024 was a landmark year for Biopôle-based companies, underscoring the campus’s reputation as a premier hub for life sciences innovation. With over CHF 246 million secured in funding, 25 new companies joining, significant commercial partnerships, and groundbreaking research advancements, Biopôle has been cultivating for 20 years a thriving ecosystem that propels healthcare and biotechnology forward.…
Read MoreDr. Jasmine Abdulcadir Wins Leenaards Scientific Prize
Dr. Jasmine Abdulcadir (HUG) in collaboration with Prof. Daniel Huber (UNIGE), focuses on improving the understanding and evaluation of female genital sensitivity, a field still lacking in objective clinical tools—particularly in the context of female genital mutilation (FGM). A pioneering portable, connected device will be developed to allow women to assess the sensitivity of…
Read More